EUCTR2007-006082-32-IT进行中（未招募）不适用
Female steroid hormones and protection from cardiovascular risk: staminal endothelial progenitor cells and menopause. - ND
AZIENDA OSPEDALIERA PISANA0 个研究点开始时间: 2008年5月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •a) regular menstrual cycles; b) presence of both ovaries; c) surgical procedure of bilateral annessiectomy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •a) treatment with estrogens, estroprogestins or GnRH analogues in previous 3 months; b) oligoamenorrhoea; c) hypertension; d) diabetes mellitus; e) smoke; f) hyperlipidemia; g) obesity; h) positive medical history of cardiovascular diseases; i) positive medical history of malignant diseases; renal insufficiency, cerebrovascular diseases; l) therapy with statins, low-dose aspirin and erythropoietin.
研究者
相似试验
已完成
不适用
Sex Steroid Hormones and Risk of CHD in WomenCardiovascular DiseasesHeart DiseasesCoronary DiseasePostmenopauseCoronary ArteriosclerosisNCT00006407National Heart, Lung, and Blood Institute (NHLBI)
已完成
2 期
Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young WomenCardiovascular Risk ReductionNCT03815929Mayo Clinic35
已完成
不适用
The Sex Hormones And Physical Exercise studyCancerISRCTN11633173The National Cancer Fund (Koningin Wilhelmina Fonds [KWF]) (The Netherlands)189
已完成
2 期
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal WomenPostmenopauseHypercholesterolemiaNCT00001752National Heart, Lung, and Blood Institute (NHLBI)30
招募中
不适用
Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat ContentGender DysphoriaNCT06245681Medical University of Vienna40